The Global Bispecific Antibodies Market is valued at US$ 16.55 billion in 2025 and is projected to reach US$ 449 billion by 2034, expanding at a CAGR of 42.3% from 2025 to 2034. The market is experiencing rapid growth as pharmaceutical and biotechnology companies advance next-generation antibody therapies for cancer, autoimmune diseases, inflammatory conditions, hemophilia, ophthalmic diseases,...
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek